(Q38965072)

8 September 2017

Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements (English)

1 reference

8 September 2017

Guodong Wu

1

1 reference

8 September 2017

Zhiyong Ji

2

1 reference

8 September 2017

Haifeng Li

3

1 reference

8 September 2017

Yu Lei

4

1 reference

8 September 2017

Xiaoyuan Jin

5

1 reference

8 September 2017

Yingqing Yu

6

1 reference

8 September 2017

Mingli Sun

7

1 reference

8 September 2017

1 August 2014

1 reference

Cell Biochemistry & Function

8 September 2017

1 reference

8 September 2017

32

1 reference

8 September 2017

7

1 reference

8 September 2017

547-556

1 reference

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation

8 September 2017

1 reference

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

TRAIL death receptors and cancer therapeutics

21 January 2018

1 reference

The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer

21 January 2018

1 reference

Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells

21 January 2018

1 reference

Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.

21 January 2018

1 reference

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL.

21 January 2018

1 reference

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer

21 January 2018

1 reference

TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.

21 January 2018

1 reference

Silence from within: endogenous siRNAs and miRNAs.

21 January 2018

1 reference

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis.

21 January 2018

1 reference

Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma

21 January 2018

1 reference

miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.

21 January 2018

1 reference

MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met

21 January 2018

1 reference

Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.

21 January 2018

1 reference

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

21 January 2018

1 reference

Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers

21 January 2018

1 reference

EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups

21 January 2018

1 reference

Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer

21 January 2018

1 reference

MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises.

21 January 2018

1 reference

MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth

21 January 2018

1 reference

Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.

21 January 2018

1 reference

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.

21 January 2018

1 reference

Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.3042

1 reference

8 September 2017

1 reference